Opioid Makers Win Major Victory in California Trial
In one of the first cases to be brought against drug manufacturers over the crisis, a judge ruled that there was “simply no evidence” the companies were liable in the epidemic.
Manchin Raises Doubts on Safety Net Bill, Complicating Path to Quick Vote
Senator Joe Manchin III of West Virginia, a crucial Democratic swing vote, demanded more time to evaluate the economic and fiscal impact of the $1.85 trillion bill.
Oklahoma to Continue Lethal Injections After Man Vomits During Execution
It was the state’s first lethal injection since 2015, when it halted executions after using the wrong drug in one instance and allowing a prisoner to regain consciousness in another.
Pressure Grows on G20 Nations to Get Covid Vaccines to the Poor
The world’s leaders are focusing on preventing future pandemics, but experts say rich nations are not doing enough to help the poor survive the current one.
Why Aren’t More People Comparison Shopping for Health Plans?
Most Medicare beneficiaries don’t compare plans during open enrollment season, and may be paying more, or accepting more restrictions, than they should.
Why Aren’t More People Comparison Shopping for Health Plans?
Most Medicare beneficiaries don’t compare plans during open enrollment season, and may be paying more, or accepting more restrictions, than they should.
¿Qué vacuna de refuerzo debo elegir?
Las autoridades sanitarias de EE. UU. autorizaron la combinación de vacunas en la dosis de refuerzo contra la covid, pero no han indicado cuál es la mejor opción.
How to Decide Which Covid Booster Shot to Get
Health officials approved mix-and-match Covid booster shots, but didn’t say whether it’s better to switch vaccines or stick with your original shot.
Fluvoxamine Helps Lower Risk of Hospitalization From Covid, Study Finds
Scientists say the results of the latest research examining the inflammation-fighting qualities of fluvoxamine, capping similar smaller studies, could lead to new treatment guidelines.
Merck Will Share Formula for its Covid Pill With Poor Countries
The company announced a licensing deal that will allow the drug, molnupiravir, to be made and sold cheaply in 105 developing nations.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.